According to Fox News, Rosie O'Donnell publicly credited Mounjaro, a weight loss medication produced by Eli Lilly, for her significant weight loss, leading to a surge in social media engagement and heightened interest in health-focused investments. With Eli Lilly’s stock (LLY) already showing bullish momentum due to the popularity of its GLP-1 drugs, this high-profile endorsement is expected to further influence trading volumes and investor sentiment. Crypto traders are also monitoring the growing intersection between pharmaceutical breakthroughs and health-related blockchain projects, as positive sentiment in the health sector can drive demand for digital health tokens and related DeFi platforms. Source: Fox News Twitter, May 25, 2025.